Status:
COMPLETED
Immune Modulation by Parenteral Lipids
Lead Sponsor:
Radboud University Medical Center
Conditions:
Infections
Total Parenteral Nutrition
Eligibility:
All Genders
18-80 years
Phase:
NA
Brief Summary
Immune modulating properties of parenteral lipid emulsions seem to contribute to the increased risk for infections which remains associated with the use of total parenteral nutrition. Emulsions based ...
Eligibility Criteria
Inclusion
- Adult (\>18 yrs of age)
- Healthy
- Willingness to give written informed consent
Exclusion
- Smoking \> 5 cigarettes/day
- Diet with \> 2 portions of fatty fish per day
- Use of oral fish oil or vitamin substrates
- History of metabolic disorder (especially diabetes or lipid disorders)
- History of allergic, inflammatory of immunological disease
- History of pulmonary, cardiovascular, renal or hematological disease
- Medication use
Key Trial Info
Start Date :
August 1 2008
Trial Type :
INTERVENTIONAL
Allocation :
ESTIMATED
End Date :
February 1 2010
Estimated Enrollment :
8 Patients enrolled
Trial Details
Trial ID
NCT00734916
Start Date
August 1 2008
End Date
February 1 2010
Last Update
February 4 2010
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
Radboud University Nijmegen Medical Centre
Nijmegen, Gelderland, Netherlands, 6500 HB